Maviret Filmtabletten

7680664720013 CH-66472 Filmtabletten

Associated product:

MAVIRET cpr pell 100mg/40mg 84 pce
Maviret Filmtabletten
Maviret Filmtabletten
Maviret Filmtabletten
1 / 3
google

Article details

Package size
84
Selling units
84
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
23/01/2024
Summary of Product Characteristics
Français
23/01/2024
Summary of Product Characteristics
Italien
23/01/2024
Patient information leaflet
Allemand
05/09/2022
Patient information leaflet
Français
05/09/2022
Patient information leaflet
Italien
05/09/2022

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
40.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
7.87 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
2.6 MG Substance HBESI

Reimbursement information

Public price
CHF 15089.40
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2017

Authorization holder

AbbVie AG

6330 Cham

Authorization information

Swissmedic authorization number
66472
Drug name
Maviret, Filmtabletten
Galenic form
FILM
ATC Code
J05AP57
Authorization status
Z
Dispensing category
A
First authorization
22/09/2017
Authorization expiration date
31/12/9999
IT Number
08.03.0.
Domain
Human medicine
Field of application
Chronische Hepatitis C

Package details

Description (FR)
MAVIRET cpr pell 100mg/40mg 84 pce
Description (DE)
MAVIRET Filmtabl 100mg/40mg 84 Stk
Market launch
22/09/2017
Narcotic (BTM)
No